Serogroup B Meningococcal Meningitis (DBCOND0039863)
Identifiers
- Synonyms
- Meningococcal Meningitis, Serogroup B / Meningitis, Meningococcal, Serogroup B
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Neisseria meningitidis serogroup b nhba fusion protein antigen Not AnnotatedNo drug targets - Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT00962624 Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults prevention 2 completed NCT00657709 Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants - Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)
- Bordetella pertussis pertactin antigen
- Bordetella pertussis toxoid antigen (formaldehyde inactivated)
- Clostridium tetani toxoid antigen (formaldehyde inactivated)
- Corynebacterium diphtheriae
- Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
- Haemophilus influenzae b polysaccharide-tetanus conjugate
- Hepatitis B Vaccine (Recombinant)
- Meningococcal polysaccharide vaccine group C
- Poliovirus type 1 antigen (formaldehyde inactivated)
- Poliovirus type 2 antigen (formaldehyde inactivated)
- Poliovirus type 3 antigen (formaldehyde inactivated)
prevention 3 completed NCT01768117 Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age No drug interventions prevention 2 completed NCT00248833 Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis. No drug interventions prevention 1 completed NCT02305446 Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ. No drug interventions prevention 3 completed